CELZ-201 Cuts Insulin Dependency at 1 Year in Patients with Type 2 Diabetes
CELZ-201 reduced insulin dependency and stabilized HbA1c in 1-year follow-up data from the AlloStem pilot study in T2D.
Related Articles
Machine Learning Model May Help to Diagnose Gout
Investigators hope that the model may serve as a foundation for future applications in gout diagnosis.
What the Experts Think About Where AI Is Headed
Everyone is talking about AI, but will it really change medicine? We spoke with leaders in the field about possibilities, common misconceptions, and what to…
Who is Speaking at INVEST 2025? – MedCity News
The healthcare investor conference, scheduled for May 20 and 21 at the Willis Tower in Chicago, combines panel discussions, networking opportunities, and a startup pitch…
CLEAR is Under Construction in Epic Toolbox to Streamline Patient Experiences in Healthcare
Out-of-the-box integration will unlock a reusable, connected health identity that simplifies patient identity verification and enhances security……
Business Shorts: Partnerships Advancing 5G, ASIC Design, and More
In this edition of Business Shorts, Altium acquires Part Analytics, Keysight opens a 6G research lab, and Siemens throws its support behind budding startups.
These 6 companies are using AI to streamline clinical trials for pharma
Streamlining processes like trial site selection and FDA documentation can make a meaningful difference in development timelines.
What Is Long-Term Follow-Up in Bariatric Surgery? A Proposal
Obesity Surgery – Gastric bypass surgery is a highly effective treatment for morbid obesity, offering significant and sustained weight loss and improvement in comorbid conditions.…
Priority Index for Bariatric Surgery Based on a New Classification of Severity in Obesity
Obesity Surgery – This study aimed to propose and evaluate a severity rating in obesity (SERO) based on a new priority index for bariatric surgery…
Do GLP-1–Receptor Agonists Increase Risk for Thyroid Cancer?
Glucagon-like peptide-1–receptor agonists (GLP-1–RAs) are widely used for type 2 diabetes and obesity management, but concerns have emerged regarding